InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

20 October 2025

Name:

LIFESPOT HEALTH LTD (LSH)
(This company subsequently changed its name to INHALERX LIMITED. You should refer to that name for Status.)

ISIN:

AU000000LSH7

Date of Listing:

11 January 2017

Subsequent Names:

Company Name	Start Date	End Date
INHALERX LIMITED	06/10/2021

Stock Exchange Status: (updated daily)

This company subsequently changed its name to INHALERX LIMITED. You should refer to that name for Stock Exchange Status.

Legal Status: (updated monthly)

ACN: 611 845 820ABN: 90 611 845 820
Registration Date: 13 April 2016

This company subsequently changed its name to INHALERX LIMITED. You should refer to that name for Legal Status.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

This company subsequently changed its name and is now INHALERX LIMITED. You should refer to that name for Capital Gains Tax Status.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

LIFESPOT HEALTH LTD(LSH)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
INHALERX LIMITED	06/10/2021
LIFESPOT HEALTH LTD		06/10/2021

Shareholder links

Our website ranking of LSH:

(5 out of 5)

COMPANY WEBSITE:

LSH website

LSH email

LSH investorRelations

LSH announcements

LSH annualreports

LSH directors

REGISTRY:

Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000LSH7

Address: Suite 103, Level 1, 2 Queen Street, Melbourne VIC 3000
Tel: +61 (0) 3 8395 5446 Fax: +61 (0) 3 8678 1747

Date first listed: 11/01/2017
Company Secretary:
Sector: Health Care Equipment & Services Industry Group:
Activities: Development of telemedicine mobile applications

News & Events

Expand this box to read and print

name changed to InhaleRx Limited	06/10/2021
The suspension of trading in the securities of Lifespot Health will be lifted from the commencement of trading on Friday, 2 October 2020, following the release by LSH of an announcement regarding a capital raising.	02/10/2020
The company releases an Appendix 2A.	02/10/2020
The company has issued 24,000,000 ordinary shares A$0.04 (4 cents) per share to Cannvalate Pty Ltd raising $960,000. Funds raised will be used to fund clinical trials on the Company's Medihale inhaler device and other novel cannabinoid inhalational devices, completion of the final stages of a BodyTel Fevertel workplace SaaS solution and ongoing marketing of the Fevertel home and workplace products. The company intends to allocate $770,000 towards the inhaler device clinical trials and $190,000 towards the BodyTel Fevertel product development and marketing costs.	02/10/2020
The securities of Lifespot Health Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of LSH, pending the release of an announcement regarding a capital raising.	28/09/2020
listed entity carried for record purposes only	11/01/2017

OFX Transferring Money Internationally to Free

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
24/08/2021	Darryl Davies	1,025,000	$0.098	$99,927.00
28/11/2019	Rodney Hannington	132,267	$0.039	$5,087.00
31/10/2019	Rodney Hannington	100,000	$0.050	$5,000.00
09/10/2018	Rodney Hannington	77,739	$0.087	$6,724.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Sean Williams	Non Exec Chairman	27/07/2021
Matthew Golden	CEO	12/10/2020
Darryl Davies	Non Exec Director	20/07/2021
Andrew Saich	Non Exec Director	20/07/2021
Nova Taylor	Company Secretary
Elizabeth Spooner	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.